Computational analysis of quinoline derivatives as potent topoisomerase-II inhibitors

被引:0
作者
Ankur Vaidya
Shweta Jain
Abkishek K. Jain
B. R. Prashanthakumar
Sushil K. Kashaw
Ram K. Agrawal
机构
[1] Dr. Hari Singh Gour Vishwavidyalaya University,Department of Pharmaceutical Sciences
[2] Adina College of Pharmacy,undefined
[3] JSS College of Pharmacy,undefined
来源
Medicinal Chemistry Research | 2015年 / 24卷
关键词
3D QSAR; CoMFA; PLS; Quinoline; Topoisomerase-II;
D O I
暂无
中图分类号
学科分类号
摘要
Quantitative structure–activity relationship (QSAR) is an attempt to correlate structural or property descriptors of compounds quantitatively with biological activities. QSARs currently are being applied in many disciplines, with many pertaining to drug design and environmental risk assessment. The 3D QSARs between the structures of 29 quinoline compounds and their topoisomerase-II inhibitor activity have been developed using the comparative molecular field analysis (CoMFA), comparative molecular similarity indices analysis (CoMSIA), and stepwise k nearest neighbor molecular field analysis [(SW) kNN MFA] method, and 3D QSAR models with the considerable prediction ability are obtained. The CoMFA, CoMSIA, and [(SW) kNN MFA] studies resulted in reliable and significant computational models. These models are more significant guide to trace the important chemical features with respect to the design of new potent compounds. The information obtained from the CoMFA, CoMSIA, and [(SW) kNN MFA] contour maps can be utilized for the design and development of new, more potent topoisomerase-II inhibitor.
引用
收藏
页码:383 / 393
页数:10
相关论文
共 75 条
  • [1] Ajmani S(2006)Three-dimensional QSAR using the k-nearest neighbor method and its interpretation J Chem Inf Model 46 24-31
  • [2] Jadhav K(1990)Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II J Immunol 145 2908-2913
  • [3] Kulkarni SA(2006)Topoisomerase IIα gene amplification and response to anthracycline-containing adjuvant chemotherapy in breast cancer J Clin Oncol 24 2409-2411
  • [4] Baloch Z(2005)Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3- Eur J Med Chem 40 928-934
  • [5] Cohen S(2006)]quinoline and 4-anilinofuro[3,2- Bioorg Med Chem 14 3098-3105
  • [6] Coffman FD(1997)]quinoline derivatives J Cell Sci 110 1345-1350
  • [7] Buzdar AU(2009)Synthesis and antiproliferative evaluation of certain 4-anilino-8-methoxy-2-phenylquinoline and 4-anilino- 8-hydroxy-2-phenylquinoline derivatives Bioorg Med Chem 17 3324-3331
  • [8] Chen YL(1993)When helicase and topoisomerase meet! Int Immunol 5 231-232
  • [9] Chen IL(2004)Design, synthesis, and quantitative structure–activity relationship of cytotoxic γ-carboline derivatives J Med Chem 47 1413-1422
  • [10] Wang TC(2009)Rag-1: a topoisomerase? Bioorg Med Chem Lett 19 2444-2447